Document is current
Any future updates will be listed below
-
Authors
de Sousa, Luana Guimaraes
Jovanovic, Katarina
Ferrarotto, Renata
- License Information
-
More Information
Article History
Accepted: 29 June 2022
First Online: 19 July 2022
Declarations
:
: Renata Ferrarotto reports personal fees from Regeneron-Sanofi, Ayala Pharmaceuticals, Prelude Pharmaceuticals, Bicara Therapeutics, Klus Pharma, Medscape, Carevive, Merck, and Guidepoint Global and institutional fees from AstraZeneca, Merck, Genentech, Pfizer, EMD-Serono, Ayala Pharmaceuticals, Prelude Pharmaceuticals, and Rakuten Medical not related to the topic of the submitted work. Luana Guimaraes de Sousa, and Katarina Jovanovic report no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
